You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Third-line therapy for chronic myeloid leukemia: current status and future directions
|
---|---|
Published in |
Journal of Hematology & Oncology, March 2021
|
DOI | 10.1186/s13045-021-01055-9 |
Pubmed ID | |
Authors |
Jorge Cortes, Fabian Lang |
X Demographics
The data shown below were collected from the profiles of 25 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 5 | 20% |
Spain | 3 | 12% |
Saudi Arabia | 1 | 4% |
Panama | 1 | 4% |
Mexico | 1 | 4% |
India | 1 | 4% |
Unknown | 13 | 52% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 17 | 68% |
Scientists | 4 | 16% |
Practitioners (doctors, other healthcare professionals) | 4 | 16% |
Mendeley readers
The data shown below were compiled from readership statistics for 89 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 89 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 10 | 11% |
Student > Ph. D. Student | 8 | 9% |
Researcher | 8 | 9% |
Other | 7 | 8% |
Student > Postgraduate | 3 | 3% |
Other | 7 | 8% |
Unknown | 46 | 52% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 10 | 11% |
Biochemistry, Genetics and Molecular Biology | 8 | 9% |
Agricultural and Biological Sciences | 6 | 7% |
Pharmacology, Toxicology and Pharmaceutical Science | 6 | 7% |
Immunology and Microbiology | 4 | 4% |
Other | 6 | 7% |
Unknown | 49 | 55% |
Attention Score in Context
This research output has an Altmetric Attention Score of 20. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 February 2024.
All research outputs
#1,883,956
of 25,856,138 outputs
Outputs from Journal of Hematology & Oncology
#141
of 1,310 outputs
Outputs of similar age
#51,266
of 470,961 outputs
Outputs of similar age from Journal of Hematology & Oncology
#8
of 46 outputs
Altmetric has tracked 25,856,138 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,310 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.6. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 470,961 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 46 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 82% of its contemporaries.